Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study)

Affiliations

• ¹ Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
• ² Department of Medical Oncology, Shimane University Hospital, Shimane, Japan.
• ³ Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
• ⁴ Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
• ⁵ Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
• ⁶ Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
• ⁷ Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama Japan.